The consistent direction of effect for remission across cohorts, along with an overall trend favoring IV ketamine for response despite some individual study variability in effect direction, coupled with negligible statistical heterogeneity for both outcomes ( I 2 = 0), strengthens its internal validity.
← all excerpts
Intravenous ketamine versus esketamine for depression: a systematic review and meta-analysis.
1
—
—